Show simple item record

dc.contributor.authorAhmedzai, S*
dc.contributor.authorSnowden, J*
dc.contributor.authorCox, A*
dc.contributor.authorCairns, D*
dc.contributor.authorWilliams, C*
dc.contributor.authorHockaday, A*
dc.contributor.authorCavenagh, J*
dc.contributor.authorParrish, C*
dc.contributor.authorYong, K*
dc.contributor.authorCavet, James*
dc.contributor.authorHunter, H*
dc.contributor.authorBird, J*
dc.contributor.authorAshcroft, J*
dc.contributor.authorBrown, J*
dc.contributor.authorMorris, C*
dc.contributor.authorCook, G*
dc.date.accessioned2016-03-30T09:37:47Zen
dc.date.available2016-03-30T09:37:47Zen
dc.date.issued2015en
dc.identifier.citationPatient-reported outcomes (PRO) in the setting of relapsed myeloma: the influence of treatment strategies and genetic variants predict quality of life and pain experience. 2015, 126 (23): Blooden
dc.identifier.urihttp://hdl.handle.net/10541/603995en
dc.language.isoenen
dc.titlePatient-reported outcomes (PRO) in the setting of relapsed myeloma: the influence of treatment strategies and genetic variants predict quality of life and pain experience.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Oncology, University of Sheffield, Sheffielden
dc.identifier.journalBlooden


This item appears in the following Collection(s)

Show simple item record